Xi Zheng
- Molecular Biology top 2%
- Cancer Research top 2%
- Molecular Medicine top 0.5%
- Plant Science top 5%
- Pharmacology top 1%
- Topics
- Natural product bioactivities and synthesis (35 papers)Curcumin's Biomedical Applications (28 papers)Cancer, Lipids, and Metabolism (21 papers)
- Partner nations
- ChinaUnited StatesPoland
In The Last Decade
Xi Zheng
197 papers receiving 6.4k citations
Hit Papers
Peers
Comparison fields: 5 of 155
- Molecular Biology 2.9k
- Cancer Research 915
- Molecular Medicine 831
- Plant Science 683
- Pharmacology 638
Countries citing papers authored by Xi Zheng
This map shows the geographic impact of Xi Zheng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xi Zheng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xi Zheng more than expected).
Fields of papers citing papers by Xi Zheng
This network shows the impact of papers produced by Xi Zheng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xi Zheng. The network helps show where Xi Zheng may publish in the future.
Co-authorship network of co-authors of Xi Zheng
This figure shows the co-authorship network connecting the top 25 collaborators of Xi Zheng. A scholar is included among the top collaborators of Xi Zheng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xi Zheng. Xi Zheng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 1 | |
| 3 | 22 | |
| 4 | 3 | |
| 5 | 7 | |
| 6 | 14 | |
| 7 | 0 | |
| 8 | 2 | |
| 9 | 2 | |
| 10 | 19 | |
| 11 | 32 | |
| 12 | 107 | |
| 13 | 27 | |
| 14 | 9 | |
| 15 | 28 | |
| 16 | 32 | |
| 17 | 64 | |
| 18 | 63 | |
| 19 | 88 | |
| 20 | 38 |
About Xi Zheng
Xi Zheng is a scholar working on Molecular Medicine, Cancer Research and Biochemistry, having authored 203 papers that have together received 6.5k indexed citations. Recurring topics across this work include Natural product bioactivities and synthesis (35 papers), Curcumin's Biomedical Applications (28 papers) and Cancer, Lipids, and Metabolism (21 papers). The work is most often cited by research in Molecular Medicine (831 citations), Biochemistry (418 citations) and Cancer Research (915 citations). Xi Zheng has collaborated with scholars based in China, United States and Poland. Frequent co-authors include Zhiyun Du, Chi Kwan Tsang, Kun Zhang, Yan He, Dongli Li, Yanjie Zhang, Allan H. Conney, Yuan Yue, Haiyan Qi and Leroy F. Liu. Their work appears in journals such as Nucleic Acids Research, Journal of Clinical Investigation and Nature Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.